Health
Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities – News-Medical.Net
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications…
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
In a review article in Trends in Cancer, the team presented evidence that immunotherapies such as immune checkpoint inhibitors (which enable T cells to attack and kill cancer…
-
Noosa News23 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Noosa News23 hours agoWilliam Robinson dies aged 89
-
General23 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
General22 hours agoMatt Wright wanted to hinder investigations into chopper crash ‘at almost any cost’, jury hears